Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (SHE:002223)
China · Delayed Price · Currency is CNY 27.81
-0.35 (-1.24%)
Aug 4, 2026, 3:04 PM CST
SHE:002223 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 28,109 | 38,141 | 36,563 | 34,221 | 31,529 | 37,427 | |
Market Cap Growth | -19.66% | 4.32% | 6.84% | 8.54% | -15.76% | 32.34% |
Enterprise Value | 27,312 | 30,826 | 30,061 | 28,610 | 27,819 | 34,519 |
Last Close Price | 28.16 | 37.38 | 34.94 | 32.08 | 29.03 | 34.01 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 21.95 | 25.74 | 20.25 | 14.28 | 19.77 | 25.25 |
Forward PE | 17.05 | 18.24 | 16.38 | 15.21 | 20.02 | 23.88 |
PS Ratio | 3.56 | 4.80 | 4.83 | 4.29 | 4.44 | 5.43 |
PB Ratio | 2.04 | 2.86 | 2.89 | 2.87 | 3.13 | 4.44 |
P/TBV Ratio | 2.32 | 3.26 | 3.34 | 3.37 | 3.83 | 5.74 |
P/FCF Ratio | 21.36 | 27.76 | 21.66 | 17.16 | 16.37 | 40.82 |
P/OCF Ratio | 19.49 | 25.38 | 20.13 | 16.09 | 13.68 | 31.16 |
PEG Ratio | - | 0.60 | 0.60 | 0.63 | 0.99 | 0.99 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 3.46 | 3.88 | 3.97 | 3.59 | 3.92 | 5.01 |
EV/EBITDA Ratio | 22.29 | 22.03 | 18.47 | 12.80 | 17.54 | 20.58 |
EV/EBIT Ratio | 28.60 | 26.55 | 21.25 | 14.10 | 20.06 | 23.17 |
EV/FCF Ratio | 20.75 | 22.44 | 17.81 | 14.35 | 14.45 | 37.65 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.10 | 0.21 | 0.18 |
Debt / EBITDA Ratio | 0.03 | 0.03 | 0.03 | 0.55 | 1.31 | 0.90 |
Debt / FCF Ratio | 0.03 | 0.03 | 0.03 | 0.62 | 1.10 | 1.65 |
Net Debt / Equity Ratio | -0.07 | -0.04 | -0.52 | -0.50 | -0.52 | -0.37 |
Net Debt / EBITDA Ratio | -0.76 | -0.39 | -4.04 | -2.67 | -3.30 | -1.88 |
Net Debt / FCF Ratio | -0.69 | -0.39 | -3.90 | -3.00 | -2.72 | -3.44 |
Asset Turnover | 0.47 | 0.50 | 0.48 | 0.51 | 0.52 | 0.63 |
Inventory Turnover | 3.27 | 2.71 | 2.66 | 2.68 | 2.67 | 3.21 |
Quick Ratio | 0.80 | 0.88 | 2.84 | 2.74 | 2.55 | 3.02 |
Current Ratio | 2.35 | 1.54 | 3.44 | 3.27 | 3.10 | 3.75 |
Return on Equity (ROE) | 9.56% | 11.41% | 14.69% | 21.62% | 17.01% | 18.64% |
Return on Assets (ROA) | 3.58% | 4.58% | 5.59% | 8.16% | 6.40% | 8.44% |
Return on Invested Capital (ROIC) | 6.63% | 10.83% | 21.98% | 31.44% | 23.45% | 25.95% |
Return on Capital Employed (ROCE) | 6.80% | 8.50% | 10.90% | 15.50% | 11.60% | 14.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 4.57% | 3.89% | 4.94% | 7.00% | 5.06% | 3.96% |
FCF Yield | 4.68% | 3.60% | 4.62% | 5.83% | 6.11% | 2.45% |
Dividend Yield | 2.13% | 1.60% | 2.29% | 2.49% | 2.07% | 0.88% |
Payout Ratio | 62.16% | 53.92% | 67.81% | 27.57% | 21.99% | 21.51% |
Buyback Yield / Dilution | -0.41% | -0.36% | -0.35% | -0.35% | 0.42% | 1.02% |
Total Shareholder Return | 1.73% | 1.24% | 1.94% | 2.15% | 2.49% | 1.90% |